Do weight loss peptides increase cancer risk?

GLP-1 agonists have a boxed warning for thyroid C-cell tumors based on rodent studies. Human epidemiological data shows no clear increased cancer risk after 10+ years of monitoring. <a href='https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-investigating-reports-possible-increased-risk-pancreatitis-and' target='_blank'>FDA cancer risk assessment</a>